ArticlePharmacoEconomics1992
Recombinant granulocyte colony-stimulating factor (rG-CSF): pharmacoeconomic considerations in chemotherapy-induced neutropenia.
D Faulds et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papertrialcites it